{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:19:10Z","timestamp":1707524350412},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,18]]},"DOI":"10.7759\/cureus.17273","type":"journal-article","created":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T12:24:34Z","timestamp":1629289474000},"source":"Crossref","is-referenced-by-count":0,"title":["Posterior Reversible Encephalopathy Syndrome in a Patient With Macrophage Activation Syndrome and Herpes Simplex Virus 2"],"prefix":"10.7759","author":[{"given":"Joshua D","family":"Luster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Galindo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-016-8377-8","article-title":"Posterior reversible encephalopathy syndrome","volume":"264","author":"Fischer M","year":"2017","unstructured":"Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome. J Neurol. 2017, 264:1608-16. 10.1007\/s00415-016-8377-8","journal-title":"J Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2009.0590","article-title":"Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings","volume":"85","author":"Fugate JE","year":"2010","unstructured":"Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc. 2010, 85:427-32. 10.4065\/mcp.2009.0590","journal-title":"Mayo Clin Proc"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23402","article-title":"Tacrolimus-associated posterior reversible encephalopathy syndrome in hematopoietic allogeneic stem cell transplantation","volume":"88","author":"Hammerstrom AE","year":"2013","unstructured":"Hammerstrom AE, Howell J, Gulbis A, Rondon G, Champlin RE, Popat U. Tacrolimus-associated posterior reversible encephalopathy syndrome in hematopoietic allogeneic stem cell transplantation. Am J Hematol. 2013, 88:301-5. 10.1002\/ajh.23402","journal-title":"Am J Hematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2014-0149","article-title":"Posterior reversible encephalopathy syndrome in patients with cancer","volume":"20","author":"Singer S","year":"2015","unstructured":"Singer S, Grommes C, Reiner AS, Rosenblum MK, DeAngelis LM. Posterior reversible encephalopathy syndrome in patients with cancer. Oncologist. 2015, 20:806-11. 10.1634\/theoncologist.2014-0149","journal-title":"Oncologist"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-3055-2","article-title":"The spectrum of posterior reversible encephalopathy in systemic lupus erythematosus","volume":"34","author":"Budhoo A","year":"2015","unstructured":"Budhoo A, Mody GM. The spectrum of posterior reversible encephalopathy in systemic lupus erythematosus. Clin Rheumatol. 2015, 34:2127-34. 10.1007\/s10067-015-3055-2","journal-title":"Clin Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00111-8","article-title":"Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions","volume":"14","author":"Fugate JE","year":"2015","unstructured":"Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol. 2015, 14:914-25. 10.1016\/S1474-4422(15)00111-8","journal-title":"Lancet Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A0549","article-title":"Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome","volume":"28","author":"Bartynski WS","year":"2007","unstructured":"Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol. 2007, 28:1320-7. 10.3174\/ajnr.A0549","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21838","article-title":"Severe neurologic side effects in patients being treated for hemophagocytic lymphohistiocytosis","volume":"52","author":"Thompson PA","year":"2009","unstructured":"Thompson PA, Allen CE, Horton T, Jones JY, Vinks AA, McClain KL. Severe neurologic side effects in patients being treated for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2009, 52:621-5. 10.1002\/pbc.21838","journal-title":"Pediatr Blood Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2015.06.010","article-title":"Macrophage activation syndrome","volume":"29","author":"Ravelli A","year":"2015","unstructured":"Ravelli A, Dav\u00ec S, Minoia F, Martini A, Cron RQ. Macrophage activation syndrome. Hematol Oncol Clin North Am. 2015, 29:927-41. 10.1016\/j.hoc.2015.06.010","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0172","article-title":"Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation","volume":"100","author":"Henter JI","year":"2002","unstructured":"Henter JI, Samuelsson-Horne A, Aric\u00f2 M, et al.. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood. 2002, 100:2367-73. 10.1182\/blood-2002-01-0172","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1086\/343739","article-title":"Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review","volume":"186 Suppl 1","author":"Smith JS","year":"2002","unstructured":"Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis. 2002, 186 Suppl 1:S3-28. 10.1086\/343739","journal-title":"J Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/66748-posterior-reversible-encephalopathy-syndrome-in-a-patient-with-macrophage-activation-syndrome-and-herpes-simplex-virus-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:50Z","timestamp":1707507230000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/66748-posterior-reversible-encephalopathy-syndrome-in-a-patient-with-macrophage-activation-syndrome-and-herpes-simplex-virus-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,18]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.17273","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,18]]}}}